August 30, 2024
AminoChain, a pioneering company in the decentralized science (DeSci) space, has successfully raised $7 million in an unspecified series of venture funding. This significant investment will bolster AminoChain’s mission to revolutionize the bio-sample marketplace by tokenizing stem cells.
Project | Latest Raise | Latest Raise Date | Stage | Category |
|---|---|---|---|---|
AminoChain | $7M | August 30, 2024 | Venture Funding | DeSci |
AminoChain serves as a crucial link between biobanks, clinical sites, and bio-pharma companies. By providing a secure and efficient platform for the exchange of bio-samples, AminoChain aims to enhance collaboration and innovation in the biomedical field. This funding will enable the company to expand its operations and further develop its unique marketplace, driving advancements in stem cell research and applications.
About AminoChain
AminoChain is a platform that connects global inventories of bio-samples and research data. It aims to power the next generation of pre-clinical research by allowing users to query sample collections, maintain ownership of their assets, and build networks of collaborators. The platform focuses on tokenizing and incentivizing stem cell donations, making it easier for biobanks and clinical sites to connect with bio-pharma companies.
Website: https://aminochain.io/
A central focus of investor activity in the cryptocurrency space is the evaluation of new crypto projects to invest in, particularly those with huge potential. This blog provides insight into what new ventures are benefiting from venture capital support (VC funding in crypto). These new crypto projects, funded by professional investors, can dictate the next narrative in crypto and the next big crypto movers.
Comments